| Serial Number | 79419666 |
| Word Mark | IOMX |
| Filing Date | Wednesday, December 18, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, June 16, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical diagnostic medical and veterinary preparations; pharmaceutical preparations and formulations and medicinal health preparations for use in the treatment or prevention of diseases, ailments and disorders in humans and animals, in particular circulatory, respiratory, endocrine, neurological, cardiovascular, nutritional, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, ailments and disorders and the treatment and prevention of complications associated with such diseases, ailments and disorders; pharmaceutical preparations and formulations and medicinal health preparations for use in the treatment or prevention of illnesses, ailments and disorders in humans and animals, in particular bone, sensory organ, viral, urinary tract, kidney, metabolic and central nervous system diseases, complaints and disorders and the treatment or prevention of complications associated with such diseases, ailments and disorders; pharmaceutical preparations and formulations and medicinal health preparations for use in the treatment or and prevention of diseases, ailments and disorders in humans and animals, in particular infectious, autoimmune or and immunological, cell proliferative and oncological diseases, ailments and disorders, cancers, tumours and metastases and the treatment and prevention of complications associated with such diseases, ailments and disorders; pharmaceutical preparations and formulations and medical health preparations, in particular artificial polypeptides and proteins, in particular antibodies and antibody-like polypeptides and proteins, and nucleic acid coding for these, in particular for use in the following areas: treatment and prevention of various types of cancer, inflammatory diseases and autoimmune diseases; diagnostic preparations and biomarker reagents for medical and veterinary purposes; diagnostic preparations and diagnostic biomarker reagents for the diagnosis and prognosis of human and animal diseases, ailments and disorders, in particular circulatory, respiratory, endocrine, neurological, cardiovascular, nutritional, pulmonary, musculoskeletal, lymphatic or and gastrointestinal diseases, ailments and disorders and the diagnosis and prognosis in relation to complications associated with such diseases, ailments and disorders; diagnostic preparations and diagnostic biomarker reagents for medical purposes, namely, for the diagnosis and prognosis of human and animal diseases, ailments and disorders, in particular bone, sensory organ, virus, urinary tract, kidney, metabolic and central nervous system diseases, ailments and disorders and the diagnosis and prognosis in relation to complications associated with such diseases, ailments and disorders; diagnostic preparations and diagnostic biomarker reagents for medical purposes, namely, for the diagnosis and prognosis of diseases, ailments and disorders in humans and animals, in particular infectious, autoimmune and immunological, cell proliferative and oncological diseases, ailments and disorders, cancers, tumours and metastases and the diagnosis and prognosis in relation to complications associated with such diseases, ailments and disorders. |
| Goods and Services | Chemical preparations for scientific and general industrial manufacturing purposes; Biochemical preparations, namely, genetically engineered polypeptides, for scientific purposes and proteins in raw material form for scientific and medical research, in particular antibodies and antibody-like polypeptides and proteins, and nucleic acid coding sequences for these for scientific purposes, in particular artificial polypeptides and proteins and nucleic acid coding sequences for these for scientific purposes; diagnostic preparations, except for medical or veterinary use. |
| Goods and Services | Scientific services, namely, scientific research in the field of biology, chemistry or medicine, as well as immunology, oncology, molecular biology, cell biology, biochemistry and medicinal chemistry, and relating to the discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic agents and diagnostic biomarker reagents and diagnostic apparatus; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of platform technology, namely a cancer immunotherapy platform for the production of therapeutics; chemical, biological and biochemical laboratory services; conducting chemical, biochemical and biological analyses; Medical and scientific research in the field of cancer diagnostics for scientific purposes; Biological and biochemical research laboratory services; Forensic pathological biological and biochemical examination services; providing technical and scientific research information in the field of biotechnology about a biotechnology company, its technologies, projects, product candidates, products and services via a web site on a global computer network; software design and development; design and development of computer software for use in the fields of biology, chemistry or medicine, in particular immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry, as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents and diagnostic apparatus. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 20, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 20, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 20, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | iOmx Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, March 20, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 21, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 21, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, June 4, 2025 | ASSIGNED TO EXAMINER |
| Friday, June 6, 2025 | NON-FINAL ACTION WRITTEN |
| Sunday, June 8, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, July 29, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, July 29, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, August 15, 2025 | REFUSAL PROCESSED BY IB |
| Tuesday, January 27, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 27, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 27, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 27, 2026 | NON-FINAL ACTION WRITTEN |
| Friday, February 27, 2026 | NON-FINAL ACTION E-MAILED |
| Friday, February 27, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 26, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 26, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 26, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 16, 2026 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 16, 2026 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 16, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |